Nurse Practitioner in Scranton, IA Accepting Medicare
1 Nurse Practitioner nurses found. Showing 1 - 1
 Mary Christine Pope, ARNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1023 E Avenue, Scranton, IA 51462 Phone: 712-830-3157 |
News Archive
Researchers investigate whole-genome data to uncover new mutations for CAD risk
The Coronary ARtery DIsease Genome-wide Replication And Meta-Analysis (CARDIoGRAM) published in Circulation Cardiovascular Genetics, an American Heart Association journal consists of data from every published whole-genome study on genetic mutations in heart attack or CAD risk. Researchers are also pooling data from several unpublished genome-wide association studies to see if any new mutations can be uncovered.
Powerful new mass spectrometry systems and solutions for life-science research, clinical research, pharma and applied markets announced by Bruker
At the 61st ASMS Conference on Mass Spectrometry and Allied Topics, Bruker today announced mass spectrometry-based product introductions for life-science and clinical research, for biotech/pharma/CRO customers, as well as for industrial and applied markets. The new mass spectrometry systems and solutions are designed to deliver confident analyses with dramatically enhanced resolution, sensitivity and precision.
MFSI awarded series of new patents for identifying air-borne pathogens
Microfluidic Systems, a privately-held company, announced today it has been awarded a series of new patents covering both the components and integrated systems that perform fully automated sample collection through identification of air-borne pathogens such as bacteria, viruses, and toxins. Patent number 7,705,739 entitled "Integrated Airborne Substance Collection and Detection System" covers a combined instrument in which a detect-to-warn component is integrated with a detect-to-treat system.
Bayer HealthCare receives FDA approval for Adempas tablets
Bayer HealthCare announced today that the United States Food and Drug Administration has approved Adempas (riociguat) tablets for: (i) the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (WHO Group 4) after surgical treatment or inoperable CTEPH to improve exercise capacity and WHO functional class; and (ii) the treatment of adults with pulmonary arterial hypertension (WHO Group 1) to improve exercise capacity, improve WHO functional class and delay clinical worsening.
› Verified 2 days ago